Literature DB >> 31088152

Impaired Cardiovascular Magnetic Resonance-Derived Rapid Semiautomated Right Atrial Longitudinal Strain Is Associated With Decompensated Hemodynamics in Pulmonary Arterial Hypertension.

Shuang Leng1, Yang Dong2, Yang Wu3, Xiaodan Zhao1, Wen Ruan1, Gangcheng Zhang3, John C Allen4, Angela S Koh1,4, Ru-San Tan1,4, James W Yip5,6, Ju Le Tan1,4, Yucheng Chen2, Liang Zhong1,4.   

Abstract

Background The transition of right ventricle (RV) from a compensated to decompensated state contributes to survival in pulmonary arterial hypertension (PAH). This study investigates the significance of right atrial (RA) dysfunction on disease progression in PAH. Methods Eighty patients with PAH, including 58 with hemodynamically compensated RV function (PAH-C) and 22 with decompensated RV function (PAH-D), were compared with 80 age-matched and sex-matched normal controls. RA longitudinal strain and strain rate (SR) parameters corresponding to reservoir (total strain ε s and strain rate SRs), conduit (passive strain ε e and strain rate SRe), and booster pump (active strain ε a and strain rate SRa) phases were derived by a rapid semiautomated method on cine cardiovascular magnetic resonance. Results In PAH compared with controls, significantly reduced RA strains and SRs were observed. Among patients with PAH, PAH-D had significantly impaired RA strains and SRs compared with PAH-C. RA total strain and passive strain were the best parameters for differentiating PAH-D from PAH-C. Lower RA strain correlated with increased RA pressure ( r=-0.57; P<0.0001), RV volume ( r=-0.37; P=0.002) and biomarker ( r=-0.53; P<0.0001), impaired RV function ( r=0.46-0.72; P<0.0001), and lower exercise capacity ( r=0.41; P<0.0001). Reduced RA strains were significantly associated with higher risk of clinical worsening in PAH. RA passive strain was the best predictor of a composite adverse event end point (Harrell's C statistic,0.75; hazard ratio,0.84; P=0.019) compared with other conventional RA and RV functional measurements. Conclusions RA phasic functions are impaired in PAH. Among patients with PAH, impaired RA strains reflect RV decompensation and higher risks and predict adverse clinical outcomes. Clinical Trial Registration https://www.clinicaltrials.gov . Unique identifier: NCT02790918.

Entities:  

Keywords:  disease progression; hemodynamics; magnetic resonance imaging; pulmonary hypertension; risk factors

Year:  2019        PMID: 31088152     DOI: 10.1161/CIRCIMAGING.118.008582

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  21 in total

1.  Association of right atrial conduit phase with right ventricular lusitropic function in pulmonary hypertension.

Authors:  Manuel J Richter; Federico Fortuni; Merle Antonia Wiegand; Antonia Dalmer; Rebecca Vanderpool; Hossein A Ghofrani; Robert Naeije; Fritz Roller; Werner Seeger; Natascha Sommer; Henning Gall; Stefano Ghio; Khodr Tello
Journal:  Int J Cardiovasc Imaging       Date:  2020-01-08       Impact factor: 2.357

2.  Detection of persistent systolic and diastolic abnormalities in asymptomatic pediatric repaired tetralogy of Fallot patients with preserved ejection fraction: a CMR feature tracking study.

Authors:  Rongzhen Ouyang; Shuang Leng; Aimin Sun; Qian Wang; Liwei Hu; Xiaodan Zhao; Qin Yan; Ru-San Tan; Liang Zhong; Yumin Zhong
Journal:  Eur Radiol       Date:  2021-01-25       Impact factor: 5.315

3.  Three-dimensional biventricular strains in pulmonary arterial hypertension patients using hyperelastic warping.

Authors:  Hua Zou; Shuang Leng; Ce Xi; Xiaodan Zhao; Angela S Koh; Fei Gao; Ju Le Tan; Ru-San Tan; John C Allen; Lik Chuan Lee; Martin Genet; Liang Zhong
Journal:  Comput Methods Programs Biomed       Date:  2020-01-17       Impact factor: 5.428

Review 4.  Cardiac MRI-Update 2020.

Authors:  Anke Busse; Rengarajan Rajagopal; Seyrani Yücel; Ebba Beller; Alper Öner; Felix Streckenbach; Daniel Cantré; Hüseyin Ince; Marc-André Weber; Felix G Meinel
Journal:  Radiologe       Date:  2020-11       Impact factor: 0.635

5.  Assessment of right ventricular function using cardiovascular magnetic resonance in patients with type 2 diabetes mellitus.

Authors:  Yongning Shang; Yulin Zhang; Weiling Leng; Xiaotian Lei; Liu Chen; Xiaoyue Zhou; Ziwen Liang; Jian Wang
Journal:  Quant Imaging Med Surg       Date:  2022-02

6.  Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trial.

Authors:  Thomas P Walsh; Grayson L Baird; Michael K Atalay; Saurabh Agarwal; Daniel Arcuri; James R Klinger; Christopher J Mullin; Heather Morreo; Brynn Normandin; Sruti Shiva; Mary Whittenhall; Corey E Ventetuolo
Journal:  Pulm Circ       Date:  2021-05-21       Impact factor: 3.017

Review 7.  The Predictive Value of Right Ventricular Longitudinal Strain in Pulmonary Hypertension, Heart Failure, and Valvular Diseases.

Authors:  Marijana Tadic; Nicoleta Nita; Leonhard Schneider; Johannes Kersten; Dominik Buckert; Birgid Gonska; Dominik Scharnbeck; Christine Reichart; Evgeny Belyavskiy; Cesare Cuspidi; Wolfang Rottbauer
Journal:  Front Cardiovasc Med       Date:  2021-06-17

8.  Quantitative Assessment of Left and Right Atrial Strains Using Cardiovascular Magnetic Resonance Based Tissue Tracking.

Authors:  Yang-Yang Qu; Dominik Buckert; Gen-Shan Ma; Volker Rasche
Journal:  Front Cardiovasc Med       Date:  2021-06-24

9.  Age- and Sex-Specific Changes in CMR Feature Tracking-Based Right Atrial and Ventricular Functional Parameters in Healthy Asians.

Authors:  Shuang Leng; Jiajun Guo; Ru-San Tan; Ping Chai; Lynette Teo; Marielle V Fortier; Chao Gong; Xiaodan Zhao; Ching Ching Ong; John C Allen; Wen Ruan; Angela S Koh; Teng Hong Tan; James W Yip; Ju Le Tan; Yucheng Chen; Liang Zhong
Journal:  Front Cardiovasc Med       Date:  2021-06-04

10.  Radiomics side experiments and DAFIT approach in identifying pulmonary hypertension using Cardiac MRI derived radiomics based machine learning models.

Authors:  Sarv Priya; Tanya Aggarwal; Caitlin Ward; Girish Bathla; Mathews Jacob; Alicia Gerke; Eric A Hoffman; Prashant Nagpal
Journal:  Sci Rep       Date:  2021-06-16       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.